The study delves into the molecular characterization and biocompatibility evaluation of an exopolysaccharide (EPS) produced by the moderately halophilic bacterium Virgibacillus dokdonensis VITP14 from the Kumta coast. This EPS, with a production yield of 17.3 g/L after 96 hours of fermentation, underwent purification using ion exchange and gel permeation chromatographic methods. Structural analyses revealed a heteropolysaccharide composition rich in glucose, ribose, fructose, and xylose. Various characterization techniques such as SEM, EDX, AFM, HPLC, FT-IR, NMR, TGA, XRD, and GPC unveiled the intricate details of the EPS, including morphology, elemental composition, monosaccharide content, functional groups, molecular weight, thermal stability, crystalline nature, and molecular structure.
Exploring Marine Biomaterials Potential
The demand for biomaterials in biomedical and clinical applications has surged, with natural polysaccharides gaining attention for their biocompatibility and sustainability. Marine resources have emerged as a source of bioactive polysaccharides with applications in tissue engineering, drug delivery, and more. Bacterial EPSs, being high-molecular-weight biomacromolecules, exhibit diverse properties and are investigated for their therapeutic potential in various fields.
Harnessing Halophilic Bacteria for EPS Production
While EPS production is known in microorganisms, exploration of halophilic bacteria for biopolymer synthesis remains limited. The study of halophilic microorganisms, particularly from saline environments, presents untapped potential for EPS production. The halophilic bacterium V. dokdonensis VITP14 from the Kumta coast exhibited significant EPS yield and biocompatibility, paving the way for novel biomaterial applications.
Insights into EPS Production and Characterization
The EPS production by VITP14 was optimized in Zobell marine broth, showcasing a strong correlation between growth phases and EPS biosynthesis. Purification techniques and structural analyses, including SEM, EDX, AFM, and spectroscopic methods, provided a comprehensive understanding of the EPS’s physical, chemical, and morphological attributes.
Functional Properties and Biocompatibility Assessment
The EPS displayed notable water solubility, water-holding capacity, and emulsifying activity, indicating its potential for diverse applications. Hemocompatibility studies revealed erythrocyte protection and membrane stabilization effects, essential for biomaterial acceptance in clinical settings. Cytocompatibility assessments on murine macrophages and human keratinocytes demonstrated cell viability exceeding 80%, highlighting the EPS’s biocompatibility.
Optimization and Future Prospects
The study underscores the significance of halophilic bacteria in EPS production and biomaterial development. Further optimization studies are warranted to enhance EPS yield and tailor its properties for specific biomedical applications. The biocompatibility and functional versatility of VITP14 EPS position it as a promising candidate for biomedical and tissue engineering advancements.
Key Takeaways
– Marine bacterial EPSs offer biocompatible alternatives for diverse biomedical applications.
– Halophilic bacteria like V. dokdonensis VITP14 exhibit significant EPS production potential.
– Comprehensive characterization techniques unveil the structural intricacies and functional properties of EPS.
– Biocompatibility assessments highlight the potential of VITP14 EPS for tissue engineering and drug delivery.
– Further optimization and tailored modifications can enhance the utility of marine bacterial EPSs in biomedical fields.
Tags: yeast, formulation, tissue engineering, nutraceuticals, filtration, chromatography, drug delivery
Read more on pmc.ncbi.nlm.nih.gov